Exposure, Relaxation, & Rescripting Therapy-Child
ERRT-C
1 other identifier
interventional
2
1 country
1
Brief Summary
The study implements a trauma-related nightmare treatment for children aged 8 to 13 years. Relevant outcome progress and outcome measures on symptoms, nightmare distress and duration, academic indicators, and sleep quality will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 23, 2013
CompletedFirst Posted
Study publicly available on registry
July 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedJune 20, 2016
June 1, 2016
2.3 years
July 23, 2013
June 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trauma Related Nightmare Survey - Child Version (TRNS-C) Reflecting change in nightmare frequency, severity, and duration
The TRNS-C is a 14-item self-report measure that assesses current sleep quality, frequency, severity, and duration of nightmares, as well as cognitions, emotions, and behaviors related to nightmares in children.
Participants will be assessed immediately after treatment which occurs on average for 5 weeks, and then will be assessed for follow-ups at 3 months & 6 months post treatment.
Secondary Outcomes (11)
University of California at Los Angeles Post-traumatic Stress Disorder Reaction Index for the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) (UPID)
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Revised Child Anxiety and Depression Scale (RCADS)
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Nightmare Distress Questionnaire - Modified (NDQ)
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Pittsburgh Sleep Quality Index (PSQI)
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Strength and Difficulties Questionnaire - Child Version (SDQ)
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
- +6 more secondary outcomes
Other Outcomes (10)
Trail Making Test
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Wechsler Intelligence Scale for Children (WISC-IV), Letter-Number Sequencing subtest
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
Wechsler Intelligence Scale for Children (WISC-IV), Digit Span subtest
1 wk pre-treatment & 1 wk, 3 mo, 6 mo post-treatment follow-ups
- +7 more other outcomes
Study Arms (1)
Exposure, Relaxation, & Rescripting Therapy-Child
EXPERIMENTALExposure, Relaxation, \& Rescripting Therapy-Child utilizes behavioral and cognitive therapy techniques of exposure therapy and cognitive restructuring.
Interventions
Exposure, Relaxation, \& Rescripting Therapy (ERRT) will be conducted once a week for five consecutive weeks for approximately two hours per session. Each treatment session focuses on one of the following topics/skills: psycho-education and investment in treatment, psycho-education, Progressive Muscle Relaxation, diaphragmatic breathing, child-friendly exposure to the trauma-nightmare, and rescription.
Eligibility Criteria
You may qualify if:
- children age 8-13 with PTSD Criterion A event as defined by the DSM-IV and nightmares occurring at least once per week over a minimum of one month
- have a parent or legal guardian who is able to participate in treatment assignments at home and be able to read and speak English
You may not qualify if:
- adult, no traumatic experience, no nightmares, apparent psychosis, pervasive developmental disorder, or mental retardation, not able to read and speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Montana
Missoula, Montana, 59812, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cameo Borntrager, Ph.D.
University of Montana
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology
Study Record Dates
First Submitted
July 23, 2013
First Posted
July 8, 2014
Study Start
December 1, 2012
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
June 20, 2016
Record last verified: 2016-06